Lumos Diagnostics: Doug Ward
Lumos Diagnostics' board has appointed Doug Ward CEO. He was most recently VP of strategy and business development at Hologic. Before that, Ward was CEO of Personal Genome Diagnostics. The Sarasota, Florida-based firm noted that it is preparing to launch its point-of-care test, FebriDx, if it receives 510(k) clearance from the US Food and Drug Administration. Lumos has also submitted its ViraDx and CoviDx point-of-care tests in markets including Canada and Australia.